Search
Now showing items 1-1 of 1
The determination of the effect(s) of solute carrier family 22‑member 2 (SLC22A2) haplotype variants on drug binding via molecular dynamic simulation systems
(Nature Research, 2022)
Single nucleotide polymorphisms detected in the solute carrier member family-22 has been shown to
result in a variable response in the treatment of type 2 diabetes mellitus with Metformin. This study
predicted a ...